259 related articles for article (PubMed ID: 18314200)
21. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
[TBL] [Abstract][Full Text] [Related]
22. Lamotrigine for the treatment of bipolar disorder: a clinical case series.
Suppes T; Brown ES; McElroy SL; Keck PE; Nolen W; Kupka R; Frye M; Denicoff KD; Altshuler L; Leverich GS; Post RM
J Affect Disord; 1999 Apr; 53(1):95-8. PubMed ID: 10363672
[TBL] [Abstract][Full Text] [Related]
23. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive lamotrigine treatment for adolescents with bipolar disorder: retrospective report of five cases.
Soutullo CA; Díez-Suárez A; Figueroa-Quintana A
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):357-64. PubMed ID: 16768643
[TBL] [Abstract][Full Text] [Related]
25. A Descriptive Analysis of Factors Leading to a 1-Year Remission in Bipolar Disorder.
Rapport D; Kaplish D; McGrady A; McGinnis R; Whearty K; Thomas M; Fine T
J Psychiatr Pract; 2015 Sep; 21(5):351-8. PubMed ID: 26348803
[TBL] [Abstract][Full Text] [Related]
26. Effects of lamotrigine in patients with bipolar disorder and alcohol dependence.
Rubio G; López-Muñoz F; Alamo C
Bipolar Disord; 2006 Jun; 8(3):289-93. PubMed ID: 16696832
[TBL] [Abstract][Full Text] [Related]
27. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
[TBL] [Abstract][Full Text] [Related]
28. Atypical antipsychotics as "mood stabilizers": a retrospective chart review.
Savas HA; Yumru M; Kaya MC; Selek S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1064-7. PubMed ID: 17449159
[TBL] [Abstract][Full Text] [Related]
29. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
Cruz N; Vieta E; Comes M; Haro JM; Reed C; Bertsch J;
J Psychiatr Res; 2008 Oct; 42(13):1068-75. PubMed ID: 18262204
[TBL] [Abstract][Full Text] [Related]
30. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
[TBL] [Abstract][Full Text] [Related]
31. Treatment-refractory bipolar disorder: classification to aid in clinical management.
Gajwani P
Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
[TBL] [Abstract][Full Text] [Related]
32. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression.
Schaffer A; Zuker P; Levitt A
J Affect Disord; 2006 Nov; 96(1-2):95-9. PubMed ID: 16820213
[TBL] [Abstract][Full Text] [Related]
33. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state.
Medda P; Perugi G; Zanello S; Ciuffa M; Rizzato S; Cassano GB
J ECT; 2010 Jun; 26(2):82-6. PubMed ID: 19710623
[TBL] [Abstract][Full Text] [Related]
34. Is adjunctive open-label zonisamide effective for bipolar disorder?
Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
[TBL] [Abstract][Full Text] [Related]
35. Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug.
Pacchiarotti I; Valentí M; Colom F; Rosa AR; Nivoli AM; Murru A; Sánchez-Moreno J; Vieta E
J Affect Disord; 2011 Mar; 129(1-3):321-6. PubMed ID: 20817267
[TBL] [Abstract][Full Text] [Related]
36. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of bipolar II disorder with lamotrigine].
Vieta E; Goikolea M; Benabarre A; Torrent C; Comes M; MartInez-Arán A; Reinares M; Colom F; Parramon G; Corbella B; Gastó C
Actas Esp Psiquiatr; 2003; 31(2):65-8. PubMed ID: 12677469
[TBL] [Abstract][Full Text] [Related]
38. Lamotrigine for bipolar disorder: translating research into clinical practice.
Fung J; Mok H; Yatham LN
Expert Rev Neurother; 2004 May; 4(3):363-70. PubMed ID: 15853534
[TBL] [Abstract][Full Text] [Related]
39. Long-term lamotrigine plus lithium for bipolar disorder: One year outcome.
Ghaemi SN; Schrauwen E; Klugman J; Berv DA; Shirzadi AA; Pardo TB; Goodwin FK
J Psychiatr Pract; 2006 Sep; 12(5):300-5. PubMed ID: 16998417
[TBL] [Abstract][Full Text] [Related]
40. Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.
Pan PY; Lee MS; Lo MC; Yang EL; Yeh CB
BMC Psychiatry; 2014 May; 14():145. PubMed ID: 24885966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
